HAI Pathogens and Antimicrobial Resistance Report, 2018-2021

Adult Data Tables

Print
PAGE 7 of 19

‹View Table of Contents

Related Pages

Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type, Adults, 2018-2021

Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type, Adults, 2018-2021
Acute Care Hospitals
(n=1,155 hospitals)		 LTACHs1,2
(n=110 hospitals)
Pathogen # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank
Staphylococcus aureus 4,556 29.6 1 65 18.7 2
Pseudomonas aeruginosa 2,062 13.4 2 105 30.2 1
Select Klebsiella spp. 1,869 12.1 3 38 10.9 3
Enterobacter spp. 932 6.1 4 14 4.0 7
Escherichia coli 802 5.2 5 16 4.6 6
Serratia spp. 783 5.1 6 25 7.2 4
Stenotrophomonas maltophilia 699 4.5 7 11 3.2 8
Haemophilus influenzae 628 4.1 8 0 0.0 .
Streptococcus spp. 582 3.8 9 3 0.9 14
Acinetobacter spp. 443 2.9 10 23 6.6 5
Proteus spp. 243 1.6 11 9 2.6 9
Citrobacter spp. 212 1.4 12 2 0.6 15
Coronavirus3 169 1.1 13 0 0.0 .
Moraxella catarrhalis 86 0.6 14 0 0.0 .
Virus, not specified 75 0.5 15 0 0.0 .
Other pathogen 1,244 8.1 37 10.6
Total 15,385 100.0 348 100.0

Note: Refer to Technical Resources for more information about the acronyms and terms used in this table.

Footnotes:

  1. Some rankings are not shown: Providencia stuartii (#10, 1.7%); Pseudomonas not specified and Corynebacterium striatum (#11, 1.4%); Non-fermentative gram-negative bacillus (#13, 1.1%).
  2. Citrobacter , Klebsiella not specified, and Pseudomonas putida are tied for ranking #15.
  3. Consists of pathogens reported as “human coronavirus” and SARS-CoV-2. Among those pathogens reported in this category, 167 (99%) were reported in 2020-2021.

HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Adult HAIs

  1. HAI Pathogens and Antimicrobial Resistance Report 2018-2021 Data Tables - Adult HAIs
  2. Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
  3. Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
  4. Table 3. The Top 15 HAI Pathogens Reported to NHSN
  5. Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
  6. Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type
  7. ›Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type
  8. Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type
  9. Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type
  10. Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
  11. Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume
  12. Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type
  13. Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  14. Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status
  15. Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  16. Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type
  17. Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume
  18. Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume
  19. Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI Type